These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31583707)

  • 1. Inflammatory serum markers and risk and severity of prostate cancer: The PROCA-life study.
    Stikbakke E; Richardsen E; Knutsen T; Wilsgaard T; Giovannucci EL; McTiernan A; Eggen AE; Haugnes HS; Thune I
    Int J Cancer; 2020 Jul; 147(1):84-92. PubMed ID: 31583707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study.
    Arthur R; Williams R; Garmo H; Holmberg L; Stattin P; Malmström H; Lambe M; Hammar N; Walldius G; Robinsson D; Jungner I; Van Hemelrijck M
    Int J Cancer; 2018 Jun; 142(11):2254-2262. PubMed ID: 29322512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral Inflammatory Biomarkers for Myocardial Infarction Risk: A Prospective Community-Based Study.
    Wu Z; Huang Z; Jin W; Rimm EB; Lichtenstein AH; Kris-Etherton PM; Wu S; Gao X
    Clin Chem; 2017 Mar; 63(3):663-672. PubMed ID: 28031418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediagnostic circulating markers of inflammation and risk of prostate cancer.
    Toriola AT; Laukkanen JA; Kurl S; Nyyssönen K; Ronkainen K; Kauhanen J
    Int J Cancer; 2013 Dec; 133(12):2961-7. PubMed ID: 23754532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study.
    Nyrnes A; Njølstad I; Mathiesen EB; Wilsgaard T; Hansen JB; Skjelbakken T; Jørgensen L; Løchen ML
    Gend Med; 2012 Dec; 9(6):536-547.e2. PubMed ID: 23046763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients.
    Wulaningsih W; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Van Hemelrijck M
    Carcinogenesis; 2015 Oct; 36(10):1121-8. PubMed ID: 26130675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as an inflammatory component of metabolic syndrome in Japanese.
    Oda E; Kawai R
    Intern Med; 2010; 49(2):117-24. PubMed ID: 20075574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event.
    Munkhaugen J; Otterstad JE; Dammen T; Gjertsen E; Moum T; Husebye E; Gullestad L
    Eur J Prev Cardiol; 2018 Jun; 25(9):923-931. PubMed ID: 29635941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study).
    Sigurdardottir FD; Lyngbakken MN; Holmen OL; Dalen H; Hveem K; Røsjø H; Omland T
    Am J Cardiol; 2018 Apr; 121(8):949-955. PubMed ID: 29496193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study.
    Prizment AE; Anderson KE; Visvanathan K; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):297-307. PubMed ID: 21217085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
    Hessam S; Sand M; Gambichler T; Bechara FG
    J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated inflammatory markers predict mortality in long-term ischemic stroke-survivors: a population-based prospective study.
    Frøyshov HM; Bjørnerem Å; Engstad T; Halvorsen DS
    Aging Clin Exp Res; 2017 Jun; 29(3):379-385. PubMed ID: 27146666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity CRP is an independent risk factor for all fractures and vertebral fractures in elderly men: the MrOS Sweden study.
    Eriksson AL; Movérare-Skrtic S; Ljunggren Ö; Karlsson M; Mellström D; Ohlsson C
    J Bone Miner Res; 2014 Feb; 29(2):418-23. PubMed ID: 23857741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Combination of Testosterone and White Blood Cell Count as a Predictive Factor of Overall Survival in Localized Prostate Cancer.
    Taussky D; Souliéres D; Azoulay L; Yin H; Bahig H; Bahary JP; Delouya G
    Target Oncol; 2017 Oct; 12(5):695-701. PubMed ID: 28712059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population.
    Allin KH; Bojesen SE; Nordestgaard BG
    Int J Cancer; 2016 Oct; 139(7):1493-500. PubMed ID: 27194008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of inflammation in adjuvant chemotherapy-induced sarcopenia (Izmir Oncology Group (IZOG) study).
    Oflazoglu U; Alacacioglu A; Varol U; Kucukzeybek Y; Salman T; Onal HT; Yilmaz HE; Yildiz Y; Taskaynatan H; Saray S; Butun O; Tarhan MO
    Support Care Cancer; 2020 Aug; 28(8):3965-3977. PubMed ID: 32335732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.
    Fang L; Wei H; Mak KH; Xiong Z; Song J; Wang D; Lim YL; Chatterjee S
    Can J Cardiol; 2004 Dec; 20(14):1433-8. PubMed ID: 15614337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial.
    Beer TM; Lalani AS; Lee S; Mori M; Eilers KM; Curd JG; Henner WD; Ryan CW; Venner P; Ruether JD; Chi KN;
    Cancer; 2008 Jun; 112(11):2377-83. PubMed ID: 18428198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?
    Wang AY; Woo J; Lam CW; Wang M; Sea MM; Lui SF; Li PK; Sanderson J
    J Am Soc Nephrol; 2003 Jul; 14(7):1871-9. PubMed ID: 12819248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
    Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.